T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.18% |
| 2 | Consumer Discretionary | 14.97% |
| 3 | Financials | 14.24% |
| 4 | Technology | 12.89% |
| 5 | Industrials | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
W.R. Berkley
WRB
$25.9B
| $1.16M | ﹤0.01% |
65,448
+7,813
| +14% | +$130K |
|
1652
EPR Properties
EPR
$4.7B
| $1.15M | ﹤0.01% |
14,288
+931
| +7% | +$65.5K |
|
1653
American States Water
AWR
$3.49B
| $1.15M | ﹤0.01% |
26,284
+3,005
| +13% | +$121K |
|
1654
Zebra Technologies
ZBRA
$17.9B
| $1.15M | ﹤0.01% |
23,003
+2,530
| +12% | +$147K |
|
1655
Bank of Montreal
BMO
$129B
| $1.15M | ﹤0.01% |
18,200
+200
| +1% | +$12.7K |
|
1656
Bank of Hawaii
BOH
$3.13B
| $1.15M | ﹤0.01% |
16,663
-11
| -0.1% | -$757 |
|
1657
Allison Transmission
ALSN
$10.2B
| $1.15M | ﹤0.01% |
40,570
-6,197
| -13% | -$172K |
|
|
DF
1658
DELISTED
Dean Foods Company
DF
| $1.14M | ﹤0.01% |
63,190
+19,700
| +45% | +$349K |
|
1659
Curtiss-Wright
CW
$25.4B
| $1.14M | ﹤0.01% |
13,538
-3,882
| -22% | -$313K |
|
1660
First Industrial Realty Trust
FR
$8.4B
| $1.13M | ﹤0.01% |
40,642
+922
| +2% | +$22.6K |
|
|
LNCE
1661
DELISTED
Snyders-Lance, Inc.
LNCE
| $1.13M | ﹤0.01% |
33,348
+3,567
| +12% | +$113K |
|
1662
Sarepta Therapeutics
SRPT
$1.94B
| $1.12M | ﹤0.01% |
58,868
+6,100
| +12% | +$113K |
|
|
DNR
1663
DELISTED
Denbury Resources, Inc.
DNR
| $1.12M | ﹤0.01% |
311,374
-68,186
| -18% | -$256K |
|
|
CVG
1664
DELISTED
Convergys
CVG
| $1.11M | ﹤0.01% |
44,610
-3,600
| -7% | -$97K |
|
1665
MGE Energy Inc
MGEE
$3.06B
| $1.11M | ﹤0.01% |
19,660
-1,200
| -6% | -$62.1K |
|
|
VRE
1666
DELISTED
Veris Residential
VRE
| $1.11M | ﹤0.01% |
41,013
+49
| +0.1% | +$1.25K |
|
1667
Brookdale Senior Living
BKD
$3B
| $1.11M | ﹤0.01% |
71,660
+7,100
| +11% | +$124K |
|
1668
Enbridge
ENB
$112B
| $1.1M | ﹤0.01% |
26,100
-2,600
| -9% | -$106K |
|
1669
B&G Foods
BGS
$291M
| $1.1M | ﹤0.01% |
22,793
-14,757
| -39% | -$602K |
|
1670
Mercury Insurance
MCY
$5.84B
| $1.1M | ﹤0.01% |
20,652
+3,400
| +20% | +$179K |
|
1671
Visteon
VC
$2.84B
| $1.1M | ﹤0.01% |
16,678
-9
| -0.1% | -$673 |
|
|
RPAI
1672
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $1.1M | ﹤0.01% |
64,938
+50
| +0.1% | +$810 |
|
|
MPT
1673
Medical Properties Trust
MPT
$2.51B
| $1.08M | ﹤0.01% |
71,140
+7,440
| +12% | +$105K |
|
|
GLOG
1674
DELISTED
GASLOG LTD
GLOG
| $1.08M | ﹤0.01% |
83,100
-72,000
| -46% | -$870K |
|
1675
Deluxe
DLX
$1.09B
| $1.07M | ﹤0.01% |
16,081
-1,827
| -10% | -$116K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.